SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-11-002041
Filing Date
2011-10-28
Accepted
2011-10-28 17:24:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422myr_10192011.htm SC 13G 204065
2 JOINT FILING AGREEMENT ex991to13g07422myr_10192011.htm EX-99.1 28722
  Complete submission text file 0000921895-11-002041.txt   234401
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 305 CHIPETA WAY SALT LAKE CITY UT 84108
Business Address 305 CHIPETA WAY SALT LAKE CITY UT 84108 801-214-7800
Myrexis, Inc. (Subject) CIK: 0001459450 (see all company filings)

IRS No.: 263996918 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-84958 | Film No.: 111166131
SIC: 2834 Pharmaceutical Preparations